ASTRAZENECA PLC DL-,25/ GB0009895292 /
2024-04-25 10:45:29 AM | Chg. +7.500 | Volume | Bid10:58:33 AM | Ask10:58:33 AM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
139.950EUR | +5.66% | 70 Turnover: 9,796.500 |
140.150Bid Size: 1,000 | 140.300Ask Size: 400 | 215.56 bill.EUR | - | - |
GlobeNewswire
03-28
HUTCHMED Announces Savolitinib sNDA Accepted in China for Treatment-Naïve or Previously Treated Pati...
GlobeNewswire
02-26
FibroGen Regains All Rights to Roxadustat from AstraZeneca in the United States and Other AstraZenec...
GlobeNewswire
02-05
Yiviva Announces Memorandum of Understanding with AstraZeneca to Develop Platforms, Technologies, an...
GlobeNewswire
02-02
BridgeBio Pharma Shares Positive Results of Single-Arm Phase 3 Study of Acoramidis in Japanese Patie...